Iron metabolism is crucial in various physiological processes, especially for maintaining muscle function. Previous studies have reported relationships between muscle wasting and iron overload, but the underlying mechanisms in these physiopathological conditions are incompletely characterised. The aim of this study was to characterize in vivo the impact of muscle wasting and secondary iron overload on iron regulatory proteins in skeletal muscle. For this purpose, we used murine models supplemented with iron-dextran (1g/kg), or exhibiting muscle atrophy induced by cancer cachexia (ApcMin/+) or simulated microgravity (hindlimb unloading). Histological and biomolecular analyses were performed on glycolytic skeletal muscle (i.e. quadriceps or gastrocnemius).
Despite intramuscular iron overload, iron-dextran mice do not exhibit muscle mass loss and do not seem to actively facilitate iron efflux, as indicated by the lack of changes of ferroportin and FLVCR1 proteins. Regarding atrophy models, muscle weight loss in unloaded animals is associated with iron accumulation in gastrocnemius, while muscle wasting do not induce iron excess in quadriceps in ApcMin/+mice. However, in both cases, the atrophied skeletal muscles seem to favor iron sequestration by limiting export through ferroportin. Whatever the experimental model, neither myoglobin nor FLVCR1 are modulated in skeletal muscle, suggesting that heme iron might not be specifically regulated under muscle wasting or iron overload conditions. Muscle iron metabolism appears to respond differently depending on the cause of muscle iron overload (i.e. systemic iron overload, disuse or inflammatory origin of atrophy). These results suggest a complex interplay between atrophy pathways and iron homeostasis with skeletal muscle tissue.